INNOVATIVE NEUROTECHNOLOGIES

Innovative NeuroTechnologies is a development-stage biotechnology business researching novel biologically-based and disease-modifying treatment options for a range of neurodegenerative illnesses known as tauopathies. Tau protein dysregulation is caused by several hereditary illnesses for which there are now no viable treatments, and it is largely responsible for the start of disease. They developing a pipeline of disease-modifying biotherapeutic candidates or products to prevent, delay, or mitigate underlying dementia or cognitive deficits seen in disease and other related neurodegenerative tauopathies, such as frontotemporal dementia or pick's disease, chronic traumatic encephalopathy or dementia